CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Globus Medical, Inc. - GMED CFD

90.67
0.47%
Market Trading Hours* (UTC) Opens on Tuesday at 14:30

Tue - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.48
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 90.25
Open 90.06
1-Year Change 62.83%
Day's Range 89.22 - 90.86
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 16, 2025 90.25 0.30 0.33% 89.95 91.22 89.95
Jan 15, 2025 90.37 2.17 2.46% 88.20 90.86 88.20
Jan 14, 2025 87.85 0.70 0.80% 87.15 88.33 86.25
Jan 13, 2025 86.66 0.10 0.12% 86.56 87.52 86.02
Jan 10, 2025 86.99 -1.26 -1.43% 88.25 90.08 86.17
Jan 8, 2025 86.40 3.55 4.28% 82.85 86.66 82.73
Jan 7, 2025 83.42 -0.53 -0.63% 83.95 84.25 82.97
Jan 6, 2025 83.87 1.70 2.07% 82.17 84.06 81.94
Jan 3, 2025 82.71 1.76 2.17% 80.95 82.77 80.95
Jan 2, 2025 81.75 -0.21 -0.26% 81.96 83.36 81.26
Dec 31, 2024 82.40 0.02 0.02% 82.38 82.89 82.15
Dec 30, 2024 82.31 -0.23 -0.28% 82.54 83.28 81.96
Dec 27, 2024 83.41 -0.58 -0.69% 83.99 84.23 82.55
Dec 26, 2024 83.97 1.00 1.21% 82.97 84.37 82.79
Dec 24, 2024 83.07 -0.03 -0.04% 83.10 83.44 82.60
Dec 23, 2024 82.65 0.20 0.24% 82.45 83.20 81.95
Dec 20, 2024 82.38 1.13 1.39% 81.25 83.19 81.25
Dec 19, 2024 81.85 -0.63 -0.76% 82.48 83.21 81.45
Dec 18, 2024 81.72 -2.69 -3.19% 84.41 85.33 81.62
Dec 17, 2024 83.32 2.96 3.68% 80.36 84.00 80.36

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Globus Medical, Inc. Company profile

About Globus Medical Inc

Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Globus Medical Inc revenues increased 21% to $958.1M. Net income increased 46% to $149.2M. Revenues reflect Musculoskeletal Solutions products segment increase of 17% to $876.8M, Enabling Technologies products segment increase of 100% to $81.3M, United States segment increase of 23% to $819.6M, International segment increase of 11% to $138.5M.

Equity composition

Cls A Common stock $.001 Par 8/12, 500M auth., 62,503,441 issd., Insiders own approx. 86.70%. Cls B Common Stock 275M auth., 27,885,000 issd.

Industry: Medical Equipment, Supplies & Distribution (NEC)

2560 General Armistead Ave
AUDUBON
PENNSYLVANIA 19403
US

People also watch

BTC/USD

104,515.35 Price
+4.320% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

ETH/USD

3,475.00 Price
+4.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

XRP/USD

3.29 Price
-0.550% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01639

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading